(MENAFN- PR Newswire) MILWAUKEE, April 16, 2024 /PRNewswire/ -- Ademi LLP is investigating Macatawa (Nasdaq: MCBC ) for possible breaches of fiduciary duty and other violations of law in its transaction with Wintrust.
Click here to learn how to join the or call Guri Ademi toll-free at 866-264-3995.
There is no cost or obligation to you.
In the transaction, each share of Macatawa common stock outstanding will be converted into the right to receive merger consideration paid in shares of Wintrust common stock based on Wintrust's average trading price at closing determined by a formula in the merger agreement. Subject to adjustment, the aggregate purchase price to Macatawa shareholders is currently estimated to be approximately $510.3 million, or $14.85 per share.
The transaction agreement unreasonably limits competing transactions for Macatawa by imposing a significant penalty if Macatawa accepts a competing bid. Macatawa insiders will receive substantial benefits as part of change of control arrangements.
We are investigating the conduct of Macatawa's board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.
If you own Macatawa common stock and wish to obtain additional information, please contact Guri Ademi either at [email protected] or toll-free: 866-264-3995, or .
We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
Contacts
Ademi LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001
SOURCE Ademi LLP
MENAFN16042024003732001241ID1108101346
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.